The increasing grip of several major medication corporations is raising serious concerns worldwide. This pattern towards domination frequently leads to increased medication charges, limited progress, and challenges in obtaining critical treatments for patients throughout the world. Analysts believe that stronger oversight is necessary to tackle the

India's pharmaceutical landscape presents a complex picture, largely shaped by the substantial influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of market concentration that warrants scrutiny. These incumbent companies, including entities like